Enacted in 2022, the Inflation Reduction Act (IRA) includes major provisions to make health coverage more affordable and lower prescription drug costs. It empowers Medicare to negotiate the price of certain single-source, high-priced drugs.
Tracked Litigation
3:23-cv-00156
Dayton Area Chamber of Commerce et al. v. Becerra et al.
3:23-cv-03335
Bristol Myers Squibb Co. v. Becerra et al.
1:23-cv-01615
Merck & Co., Inc. et al. v. Becerra et al.
1:25-cv-00113
Teva Pharmaceuticals USA, Inc. et al. v. Kennedy et al.
3:23-cv-20814
Novo Nordisk et al. v. Becerra et al.
3:23-cv-14221
Novartis Pharmaceuticals Corporation v. Becerra et al.
1:23-cv-00931
AstraZeneca Pharmaceuticals LP et al. v. Becerra et al.
3:23-cv-03818
Janssen Pharmaceuticals, Inc. v. Becerra et al.
Inactive Case
Inactive Case